1. Yuan B, He J, Kisoh K, et al. Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.[J]. Oncology Reports, 2016, 36(3):1377.
2. Wada M, Tsuchikawa T, Kyogoku N,etal.Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination.[J]. Anticancer Research, 2018, 38(3):1435-1444.